The tale and trials of Efgartigimod: a newly FDA approved drug for the treatment of Myasthenia gravis

Not required

Bibliographic Details
Main Authors: Kashaf Waqar, Anika Zainab
Format: Article
Language:English
Published: Pakistan Medical Association 2022-10-01
Series:Journal of the Pakistan Medical Association
Online Access:https://www.ojs.jpma.org.pk/index.php/public_html/article/view/6388
_version_ 1797820885682356224
author Kashaf Waqar
Anika Zainab
author_facet Kashaf Waqar
Anika Zainab
author_sort Kashaf Waqar
collection DOAJ
description Not required
first_indexed 2024-03-13T09:45:53Z
format Article
id doaj.art-c314b0d4f6fb47d990c30d603f104308
institution Directory Open Access Journal
issn 0030-9982
language English
last_indexed 2024-03-13T09:45:53Z
publishDate 2022-10-01
publisher Pakistan Medical Association
record_format Article
series Journal of the Pakistan Medical Association
spelling doaj.art-c314b0d4f6fb47d990c30d603f1043082023-05-25T04:21:30ZengPakistan Medical AssociationJournal of the Pakistan Medical Association0030-99822022-10-01721110.47391/JPMA.6388The tale and trials of Efgartigimod: a newly FDA approved drug for the treatment of Myasthenia gravisKashaf Waqar0Anika Zainab1Fifth Year MBBS Student, CMH Multan Institute of Medical Sciences, Multan, PakistanFifth Year MBBS Student, CMH Multan Institute of Medical Sciences, Multan, Pakistan Not required https://www.ojs.jpma.org.pk/index.php/public_html/article/view/6388
spellingShingle Kashaf Waqar
Anika Zainab
The tale and trials of Efgartigimod: a newly FDA approved drug for the treatment of Myasthenia gravis
Journal of the Pakistan Medical Association
title The tale and trials of Efgartigimod: a newly FDA approved drug for the treatment of Myasthenia gravis
title_full The tale and trials of Efgartigimod: a newly FDA approved drug for the treatment of Myasthenia gravis
title_fullStr The tale and trials of Efgartigimod: a newly FDA approved drug for the treatment of Myasthenia gravis
title_full_unstemmed The tale and trials of Efgartigimod: a newly FDA approved drug for the treatment of Myasthenia gravis
title_short The tale and trials of Efgartigimod: a newly FDA approved drug for the treatment of Myasthenia gravis
title_sort tale and trials of efgartigimod a newly fda approved drug for the treatment of myasthenia gravis
url https://www.ojs.jpma.org.pk/index.php/public_html/article/view/6388
work_keys_str_mv AT kashafwaqar thetaleandtrialsofefgartigimodanewlyfdaapproveddrugforthetreatmentofmyastheniagravis
AT anikazainab thetaleandtrialsofefgartigimodanewlyfdaapproveddrugforthetreatmentofmyastheniagravis
AT kashafwaqar taleandtrialsofefgartigimodanewlyfdaapproveddrugforthetreatmentofmyastheniagravis
AT anikazainab taleandtrialsofefgartigimodanewlyfdaapproveddrugforthetreatmentofmyastheniagravis